ID	Description	GeneRatio	BgRatio	pvalue	p.adjust	geneID	geneName	Count
hsa04610	Complement and coagulation cascades	5/56	69/5868	0.000466085556935215	0.0442781279088454	3426/624/5327/1604/722	CFI/BDKRB2/PLAT/CD55/C4BPA	5
hsa04930	Type II diabetes mellitus	4/56	48/5868	0.00105984282553454	0.0503425342128908	8651/8660/5315/9021	SOCS1/IRS2/PKM/SOCS3	4
hsa04630	Jak-STAT signaling pathway	6/56	155/5868	0.00336468965392877	0.0731918848992661	8651/2689/10379/9063/4609/9021	SOCS1/GH2/IRF9/PIAS2/MYC/SOCS3	6
hsa05200	Pathways in cancer	9/56	326/5868	0.00337093120455211	0.0731918848992661	6469/8325/6789/2353/7422/9063/4088/4609/3091	SHH/FZD8/STK4/FOS/VEGFA/PIAS2/SMAD3/MYC/HIF1A	9
hsa04920	Adipocytokine signaling pathway	4/56	68/5868	0.00385220446838242	0.0731918848992661	10891/5563/8660/9021	PPARGC1A/PRKAA2/IRS2/SOCS3	4
hsa04612	Antigen processing and presentation	4/56	76/5868	0.00573667235391981	0.0908306456037303	3303/3134/8625/3304	HSPA1A/HLA-F/RFXANK/HSPA1B	4
hsa05160	Hepatitis C	5/56	134/5868	0.00866216850137834	0.116039790784969	5519/10379/3434/9063/9021	PPP2R1B/IRF9/IFIT1/PIAS2/SOCS3	5
hsa04910	Insulin signaling pathway	5/56	138/5868	0.00977177185557634	0.116039790784969	8651/10891/5563/8660/9021	SOCS1/PPARGC1A/PRKAA2/IRS2/SOCS3	5
hsa04150	mTOR signaling pathway	3/56	52/5868	0.0130777665234327	0.129990559521553	5563/7422/3091	PRKAA2/VEGFA/HIF1A	3
hsa04310	Wnt signaling pathway	5/56	150/5868	0.0136832167917424	0.129990559521553	5519/8325/4088/4609/22943	PPP2R1B/FZD8/SMAD3/MYC/DKK1	5
hsa05142	Chagas disease (American trypanosomiasis)	4/56	104/5868	0.0168972605599497	0.145930886654111	624/5519/2353/4088	BDKRB2/PPP2R1B/FOS/SMAD3	4
hsa05210	Colorectal cancer	3/56	62/5868	0.0209350750492351	0.165736010806445	2353/4088/4609	FOS/SMAD3/MYC	3
hsa04380	Osteoclast differentiation	4/56	128/5868	0.0331677184768522	0.242379481176997	8651/10379/2353/9021	SOCS1/IRF9/FOS/SOCS3	4
hsa04010	MAPK signaling pathway	6/56	268/5868	0.0411759025809539	0.264552113715101	3303/6789/2353/4216/3304/4609	HSPA1A/STK4/FOS/MAP3K4/HSPA1B/MYC	6
hsa04144	Endocytosis	5/56	201/5868	0.0417713863760686	0.264552113715101	3303/3134/3304/4088/1601	HSPA1A/HLA-F/HSPA1B/SMAD3/DAB2	5
hsa04350	TGF-beta signaling pathway	3/56	84/5868	0.0455821775285349	0.270644179075676	5519/4088/4609	PPP2R1B/SMAD3/MYC	3
hsa05219	Bladder cancer	2/56	42/5868	0.0604076205451425	0.337571997164032	7422/4609	VEGFA/MYC	2
hsa04141	Protein processing in endoplasmic reticulum	4/56	165/5868	0.0716770533780337	0.378295559495178	3303/23645/80331/3304	HSPA1A/PPP1R15A/DNAJC5/HSPA1B	4
hsa05217	Basal cell carcinoma	2/56	55/5868	0.096414489482459	0.482072447412295	6469/8325	SHH/FZD8	2
hsa04110	Cell cycle	3/56	124/5868	0.114173087499818	0.504942935121716	902/4088/4609	CCNH/SMAD3/MYC	3
hsa03040	Spliceosome	3/56	127/5868	0.120368239799283	0.504942935121716	3303/10523/3304	HSPA1A/CHERP/HSPA1B	3
hsa05145	Toxoplasmosis	3/56	132/5868	0.13096642628249	0.504942935121716	8651/3303/3304	SOCS1/HSPA1A/HSPA1B	3
hsa00533	Glycosaminoglycan biosynthesis - keratan sulfate	1/56	15/5868	0.134120403523907	0.504942935121716	2683	B4GALT1	1
hsa04120	Ubiquitin mediated proteolysis	3/56	135/5868	0.137481337071684	0.504942935121716	8651/9063/9021	SOCS1/PIAS2/SOCS3	3
hsa05211	Renal cell carcinoma	2/56	70/5868	0.143510097350383	0.504942935121716	7422/3091	VEGFA/HIF1A	2
hsa05212	Pancreatic cancer	2/56	70/5868	0.143510097350383	0.504942935121716	7422/4088	VEGFA/SMAD3	2
hsa05416	Viral myocarditis	2/56	70/5868	0.143510097350383	0.504942935121716	3134/1604	HLA-F/CD55	2
hsa05220	Chronic myeloid leukemia	2/56	73/5868	0.153445195705647	0.520617628287018	4088/4609	SMAD3/MYC	2
hsa00531	Glycosaminoglycan degradation	1/56	19/5868	0.166794153535659	0.546394640892677	3423	IDS	1
hsa05222	Small cell lung cancer	2/56	85/5868	0.194368242610964	0.607559216886959	9063/4609	PIAS2/MYC	2
hsa00910	Nitrogen metabolism	1/56	23/5868	0.198256165510481	0.607559216886959	771	CA12	1
hsa00760	Nicotinate and nicotinamide metabolism	1/56	24/5868	0.205937543565471	0.611377082459992	4837	NNMT	1
hsa05323	Rheumatoid arthritis	2/56	91/5868	0.215344624113625	0.61773496041901	2353/7422	FOS/VEGFA	2
hsa00601	Glycosphingolipid biosynthesis - lacto and neolacto series	1/56	26/5868	0.22108409109733	0.61773496041901	2683	B4GALT1	1
hsa00052	Galactose metabolism	1/56	27/5868	0.228550590737616	0.620351603430671	2683	B4GALT1	1
hsa05216	Thyroid cancer	1/56	29/5868	0.243273322039191	0.626327119948897	4609	MYC	1
hsa00512	Mucin type O-Glycan biosynthesis	1/56	30/5868	0.250530847979559	0.626327119948897	117248	GALNT15	1
hsa00650	Butanoate metabolism	1/56	30/5868	0.250530847979559	0.626327119948897	7915	ALDH5A1	1
hsa00250	Alanine, aspartate and glutamate metabolism	1/56	32/5868	0.26484141219605	0.63072166515249	7915	ALDH5A1	1
hsa04140	Regulation of autophagy	1/56	34/5868	0.278883514487333	0.63072166515249	5563	PRKAA2	1
hsa05020	Prion diseases	1/56	35/5868	0.285805441670862	0.63072166515249	3303	HSPA1A	1
hsa05340	Primary immunodeficiency	1/56	35/5868	0.285805441670862	0.63072166515249	8625	RFXANK	1
hsa00270	Cysteine and methionine metabolism	1/56	36/5868	0.29266210123994	0.63072166515249	4507	MTAP	1
hsa05330	Allograft rejection	1/56	37/5868	0.29945409752433	0.63072166515249	3134	HLA-F	1
hsa00620	Pyruvate metabolism	1/56	40/5868	0.319448067866071	0.63072166515249	5315	PKM	1
hsa04142	Lysosome	2/56	121/5868	0.32176852661971	0.63072166515249	3423/1512	IDS/CTSH	2
hsa05332	Graft-versus-host disease	1/56	41/5868	0.325987345182389	0.63072166515249	3134	HLA-F	1
hsa04960	Aldosterone-regulated sodium reabsorption	1/56	42/5868	0.332464899441834	0.63072166515249	8660	IRS2	1
hsa00860	Porphyrin and chlorophyll metabolism	1/56	43/5868	0.338881302742771	0.63072166515249	210	ALAD	1
hsa04940	Type I diabetes mellitus	1/56	43/5868	0.338881302742771	0.63072166515249	3134	HLA-F	1
hsa03050	Proteasome	1/56	44/5868	0.345237121978205	0.63072166515249	5704	PSMC4	1
hsa03420	Nucleotide excision repair	1/56	44/5868	0.345237121978205	0.63072166515249	902	CCNH	1
hsa00514	Other types of O-glycan biosynthesis	1/56	46/5868	0.357769250076249	0.63385985908209	2683	B4GALT1	1
hsa04530	Tight junction	2/56	132/5868	0.360299288320346	0.63385985908209	5519/23136	PPP2R1B/EPB41L3	2
hsa00510	N-Glycan biosynthesis	1/56	49/5868	0.376126939874913	0.645294044078192	2683	B4GALT1	1
hsa00480	Glutathione metabolism	1/56	50/5868	0.382130873775412	0.645294044078192	2729	GCLC	1
hsa05213	Endometrial cancer	1/56	52/5868	0.393968995331949	0.645294044078192	4609	MYC	1
hsa05320	Autoimmune thyroid disease	1/56	52/5868	0.393968995331949	0.645294044078192	3134	HLA-F	1
hsa05223	Non-small cell lung cancer	1/56	54/5868	0.405584277195182	0.647529756299161	6789	STK4	1
hsa05150	Staphylococcus aureus infection	1/56	55/5868	0.411309643634306	0.647529756299161	3426	CFI	1
hsa04340	Hedgehog signaling pathway	1/56	56/5868	0.416980839222897	0.647529756299161	6469	SHH	1
hsa05221	Acute myeloid leukemia	1/56	57/5868	0.422598367268926	0.647529756299161	4609	MYC	1
hsa00230	Purine metabolism	2/56	162/5868	0.460803184229047	0.680250966569664	205/5315	AK4/PKM	2
hsa00010	Glycolysis / Gluconeogenesis	1/56	65/5868	0.465665461016367	0.680250966569664	5315	PKM	1
hsa04080	Neuroactive ligand-receptor interaction	3/56	272/5868	0.484738104028877	0.680250966569664	624/2689/59350	BDKRB2/GH2/RXFP1	3
hsa04730	Long-term depression	1/56	70/5868	0.490963312540955	0.680250966569664	5519	PPP2R1B	1
hsa03018	RNA degradation	1/56	71/5868	0.495879844879297	0.680250966569664	10140	TOB1	1
hsa05140	Leishmaniasis	1/56	72/5868	0.500749730800766	0.680250966569664	2353	FOS	1
hsa04520	Adherens junction	1/56	73/5868	0.50557340489931	0.680250966569664	4088	SMAD3	1
hsa05412	Arrhythmogenic right ventricular cardiomyopathy (ARVC)	1/56	74/5868	0.510351297794157	0.680250966569664	2697	GJA1	1
hsa04662	B cell receptor signaling pathway	1/56	75/5868	0.515083836165494	0.680250966569664	2353	FOS	1
hsa04370	VEGF signaling pathway	1/56	76/5868	0.519771442789822	0.680250966569664	7422	VEGFA	1
hsa05016	Huntington's disease	2/56	183/5868	0.525697728698223	0.680250966569664	10891/6648	PPARGC1A/SOD2	2
hsa04146	Peroxisome	1/56	79/5868	0.533568842124305	0.680250966569664	6648	SOD2	1
hsa04974	Protein digestion and absorption	1/56	81/5868	0.542550028015953	0.680250966569664	6564	SLC15A1	1
hsa03015	mRNA surveillance pathway	1/56	83/5868	0.551361309745938	0.680250966569664	5519	PPP2R1B	1
hsa05410	Hypertrophic cardiomyopathy (HCM)	1/56	83/5868	0.551361309745938	0.680250966569664	5563	PRKAA2	1
hsa04012	ErbB signaling pathway	1/56	87/5868	0.568486730562989	0.681311688591956	4609	MYC	1
hsa04640	Hematopoietic cell lineage	1/56	88/5868	0.572666758774107	0.681311688591956	1604	CD55	1
hsa04970	Salivary secretion	1/56	89/5868	0.576807011630275	0.681311688591956	1470	CST2	1
hsa04540	Gap junction	1/56	90/5868	0.580907860799457	0.681311688591956	2697	GJA1	1
hsa04912	GnRH signaling pathway	1/56	101/5868	0.623519503370063	0.709305384816549	4216	MAP3K4	1
hsa04916	Melanogenesis	1/56	101/5868	0.623519503370063	0.709305384816549	8325	FZD8	1
hsa04620	Toll-like receptor signaling pathway	1/56	102/5868	0.627175287627264	0.709305384816549	2353	FOS	1
hsa04660	T cell receptor signaling pathway	1/56	108/5868	0.64838902275716	0.724670084258003	2353	FOS	1
hsa04114	Oocyte meiosis	1/56	112/5868	0.661868122717626	0.731133391374122	5519	PPP2R1B	1
hsa04722	Neurotrophin signaling pathway	1/56	127/5868	0.708042788656915	0.767548882532835	8660	IRS2	1
hsa05012	Parkinson's disease	1/56	130/5868	0.716504782328022	0.767548882532835	6622	SNCA	1
hsa04514	Cell adhesion molecules (CAMs)	1/56	133/5868	0.724725770931944	0.767548882532835	3134	HLA-F	1
hsa04060	Cytokine-cytokine receptor interaction	2/56	265/5868	0.727151572925844	0.767548882532835	2689/7422	GH2/VEGFA	2
hsa04145	Phagosome	1/56	153/5868	0.773852245366358	0.807867728679165	3134	HLA-F	1
hsa05010	Alzheimer's disease	1/56	167/5868	0.803006376497212	0.829191367035164	6622	SNCA	1
hsa04020	Calcium signaling pathway	1/56	177/5868	0.82153741633778	0.839204887656872	624	BDKRB2	1
hsa04510	Focal adhesion	1/56	200/5868	0.857905425879256	0.867032079346057	7422	VEGFA	1
hsa04810	Regulation of actin cytoskeleton	1/56	213/5868	0.875129618345144	0.875129618345144	624	BDKRB2	1